Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apollo Hospitals Enterprise's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 48.14.
Apollo Hospitals Enterprise's Days Inventory for the
three
months ended in Mar. 2026 was 14.55.
Apollo Hospitals Enterprise's Days Payable for the
three
months ended in Mar. 2026 was 60.4.
Therefore, Apollo Hospitals Enterprise's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 2.29.
Apollo Hospitals Enterprise (BOM:508869) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Apollo Hospitals Enterprise Cash Conversion Cycle Related Terms
Apollo Hospitals Enterprise Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise Cash Conversion Cycle Chart
BOM:508869 vs HCA, THC, DVA: Cash Conversion Cycle Comparison
For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apollo Hospitals Enterprise Cash Conversion Cycle vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Apollo Hospitals Enterprise's Cash Conversion Cycle falls into.
Apollo Hospitals Enterprise Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Apollo Hospitals Enterprise's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise (BOM:508869) has a Cash Conversion Cycle of 2.29 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Apollo Hospitals Enterprise and its competitors.
Is Apollo Hospitals Enterprise's Cash Conversion Cycle too high?
Apollo Hospitals Enterprise's current Cash Conversion Cycle is 2.29. The Healthcare Providers & Services industry median Cash Conversion Cycle is 17.75. Apollo Hospitals Enterprise's value of 2.29 is 87.1% below this industry median. Overall, Apollo Hospitals Enterprise has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's Cash Conversion Cycle compare to HCA and THC?
Apollo Hospitals Enterprise's Cash Conversion Cycle of 2.29 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Conversion Cycle is 17.75. Apollo Hospitals Enterprise's value of 2.29 is 87.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Healthcare Providers & Services company?
The median Cash Conversion Cycle among Healthcare Providers & Services companies is 17.75, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apollo Hospitals Enterprise's current Cash Conversion Cycle of 2.29 is 87.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Apollo Hospitals Enterprise and its competitors. For the Healthcare Providers & Services industry, the median Cash Conversion Cycle is 17.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apollo Hospitals Enterprise's current Cash Conversion Cycle is 2.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,808.85, compared to a current price of ₹8,920.60 — trading 1.3% above its estimated fair value. The current Cash Conversion Cycle is 2.29 and 87.1% below the Healthcare Providers & Services industry median of 17.75. Apollo Hospitals Enterprise's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current Cash Conversion Cycle is 2.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be overvalued.
The current stock price of ₹8,920.60 is trading 1.3% above its estimated GF Value™ of ₹8,808.85.
GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.
Key valuation signals for BOM:508869:
Cash Conversion Cycle: 2.29
GF Value™: ₹8,808.85 vs. price of ₹8,920.60 (1.3% above fair value)
Industry Position: 87.1% below the Healthcare Providers & Services median
No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
93GF Score
Get the complete analysis for BOM:508869
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:508869 has been successfully added to your 
